US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Prescription Drugs Market Research Reports & Industry Analysis

RSS Feeds

Prescription Drugs Industry Research & Market Reports

  2    4  5  6  7  8  9  10  
Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 424200
12/10/2014 | published by: Plunkett Research, Ltd.
... save countless hours of research. Key Findings: Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors Industry (U.S.) to reach $1 trillion by 2021. Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors Industry, including Average EBITDA, Operating Ratios and Sales ...  |  read more...
USD 1,995
Estonia Pharmaceuticals and Healthcare Report Q1 2015
12/10/2014 | published by: Business Monitor International
... and Eastern European region. Low-cost generic drugs are prevalent in the market, with doctors obliged to prescribe by international nonproprietarynames (INNs), rather than branded names unless there is a specific medical reason for abranded product ...  |  read more...
USD 1,295
Croatia Pharmaceuticals and Healthcare Report Q1 2015
11/5/2014 | published by: Business Monitor International
... from pharmacies andwholesalers over its pricing policies. We forecast weak pharmaceutical market growth over the nextdecade, in light of Croatia's acceding to EU pressure to rein in its budget deficit. With Croatia's economyremaining in the ...  |  read more...
USD 1,295
Gabon Pharmaceuticals and Healthcare Report Q1 2015
11/5/2014 | published by: Business Monitor International
... has also been increased. Thiscontinued expansion, coupled with a high burden of disease, will drive the need for pharmaceuticalproducts providing opportunities for drugmakers. The continued presence of counterfeit drugs andinsufficient healthcare infrastructure are weaknesses of ...  |  read more...
USD 1,295
Lyme Disease Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries ...  |  read more...
USD 2,000
Angola Pharmaceuticals and Healthcare Report Q1 2015
11/19/2014 | published by: Business Monitor International
... spending in Angola. A new medicine depot is a step in the right direction towardsimproving the traditionally difficult operating environment of the country's pharmaceutical and healthcaremarkets. However, poor patent protection, a lack of hospitals and ...  |  read more...
USD 1,295
Cote d'Ivoire Pharmaceuticals and Healthcare Report Q1 2015
11/19/2014 | published by: Business Monitor International
... regarding thepopulation's access to treatment of infectious and chronic diseases. While the planned implementation ofuniversal healthcare coverage in 2015 will increase access to healthcare services, therefore providingdrugmakers with increased revenue-earning opportunities, we believe a continued ...  |  read more...
USD 1,295
Italy Pharmaceuticals and Healthcare Report Q1 2015
11/19/2014 | published by: Business Monitor International
... to slash public healthcare costs by EUR900mn (USD1.2bn) in 2012 and EUR1.8bn (USD2.4bn) in2013 and aims to continue to contain healthcare spending by EUR2.0bn (USD2.7bn) in 2014 andEUR2.1bn (USD2.8bn) in 2015. Headline Expenditure Projections Pharmaceuticals: ...  |  read more...
USD 1,295
Romania Pharmaceuticals and Healthcare Report Q1 2015
11/19/2014 | published by: Business Monitor International
... outlook, increasedgovernment spending is on the horizon, and that will undoubtedly benefit the pharmaceutical sector. However, stalling Eurozone growth could worsen dynamics within Romania. Headline Expenditure Projections Pharmaceuticals: RON13.96bn (USD4.17bn) in 2013 to RON14.65bn (USD4.38bn) ...  |  read more...
USD 1,295
Tanzania Pharmaceuticals and Healthcare Report Q1 2015
11/19/2014 | published by: Business Monitor International
... that favours imports of finished pharmaceuticals and a lack of skilled labour will be detrimental tolocal manufacturers, and will see the country remain reliant on imported pharmaceuticals for theforeseeable future. Headline Expenditure Projections Pharmaceuticals: TZS693.86bn ...  |  read more...
USD 1,295
Japan Pharmaceuticals and Healthcare Report Q1 2015
11/19/2014 | published by: Business Monitor International
... strong public coverage of drug expenditure. However, the cost containment measures by thegovernment including aggressively cutting medicine prices pose a downward risk to the market's long termgrowth. Risk/Reward Index Japan's Pharmaceutical Risk/Reward Index (RRI) score ...  |  read more...
USD 1,295
Kenya Pharmaceuticals and Healthcare Report Q1 2015
11/5/2014 | published by: Business Monitor International
... models to market medicines in a country that has traditionally focussed on the treatment ofinfectious diseases such as malaria, tuberculosis and HIV. Besides challenges related to diagnosis, careand treatment, there is a lack of understanding ...  |  read more...
USD 1,295
Xeristar-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Zarator-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Singulair Paediatric-API Insights, 2014
11/21/2014 | published by: DelveInsight
... large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large ...  |  read more...
USD 500
Nexium-Mups-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Pritor-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Alimta-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Lovenox With Preservative-API Insights, 2014
11/21/2014 | published by: DelveInsight
... the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a ...  |  read more...
USD 500
Velcade-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Pariet -API Insights, 2014
11/21/2014 | published by: DelveInsight
... large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large ...  |  read more...
USD 500
Tarceva-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Seroquel-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Zactos-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Tracleer-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
  2    4  5  6  7  8  9  10